Facebook Twitter Instagram YouTube Linkedin Contact

Natalie Gilbert

October 12, 2018
❮ News Articles
Share on: Facebook Twitter Linkedin

Related Articles

First Patient in Phase 1/2 Clinical Study of Gene Therapy is Treated for X-Linked RP Promising Results From Ongoing Phase 1/2 Clinical Trial for X-Linked Retinitis Pigmentosa (XLRP) Retina foundation showcases breakthroughs for treatment of age-related macular degeneration during eye on innovation conversation series A Family Forever Changed by Research The Phyllis G. & William B. Snyder Legacy Society
Mailicon
Get the Latest Updates

Sign up to receive emails from Retina Foundation that will keep you up-to-date on our research and events.

  • This field is for validation purposes and should be left unchanged.
Contact Us

Contact Us

  • This field is for validation purposes and should be left unchanged.
x

Please check all that apply:

How did you learn about the
Retina Foundation?

  • This field is for validation purposes and should be left unchanged.
  • Please check all that apply:
Contact Us

Request an Appointment

Please complete this form if you are interested in speaking to a member of our team about your AMD.

all fields required

DOWNLOAD Printable Form